Teva Pharmaceuticals USA is voluntarily recalling approximately 58,292 bottles of Methylphenidate Hydrochloride (generic Ritalin), 20 mg tablets, because the medication failed dissolution testing. This failure means the tablets may not break down properly in the body, which can result in the medication being less effective than intended. The recall affects 100-count bottles manufactured by Watson Laboratories and distributed nationwide throughout the United States and Puerto Rico.
If the medication does not dissolve correctly, the patient may receive a lower dose of the active ingredient than prescribed. This could lead to inconsistent treatment of conditions like ADHD and potentially cause symptoms to return or worsen.
Refund and medical guidance
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.